] . (2004). Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial. J Am Soc Nephrol, 3256-3262. presented at the 2004.